Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Cancer”

1,525 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,525 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04969887
What this trial is testing

Combination Immunotherapy in Rare Cancers Under InvesTigation

Who this might be right for
Advanced Biliary Tract CancerNeuroendocrine TumorsFemale Reproductive System Neoplasm+1 more
Olivia Newton-John Cancer Research Institute 240
Large-scale testing (Phase 3)UnknownNCT02381847
What this trial is testing

Radical Gastrectomy With/Without HIPEC in Advanced Gastric Cancer Patients

Who this might be right for
Malignant Neoplasm of Stomach
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 60
Testing effectiveness (Phase 2)Ended earlyNCT05500508
What this trial is testing

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Who this might be right for
CancerSolid TumorSolid Carcinoma+17 more
Aminex Therapeutics, Inc. 15
Early research (Phase 1)Active Not RecruitingNCT03502733
What this trial is testing

Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma

Who this might be right for
LymphomaMetastatic Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm+1 more
National Cancer Institute (NCI) 64
Not applicableAvailableNCT06872489
What this trial is testing

Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

Who this might be right for
Neuroblastoma in ChildrenNeuroblastoma, Recurrent, RefractoryAdvanced Cancer+7 more
Second Life Therapeutics
Testing effectiveness (Phase 2)Ended earlyNCT05824455
What this trial is testing

A Clinical Study of IMP4297 Capsule (JS109) Combined With Irinotecan in the Treatment of Advanced Malignant Solid Tumors

Who this might be right for
Advanced Solid Tumors
Shanghai Jun Pai Ying Shi Therapeutics Co., Ltd. 4
Early research (Phase 1)UnknownNCT04085185
What this trial is testing

A Study Evaluating the Safety, Tolerability, and Initial Efficacy of IBI110 in Subjects With Advanced Malignant Tumors

Who this might be right for
Advanced Malignancies
Innovent Biologics (Suzhou) Co. Ltd. 268
Testing effectiveness (Phase 2)Ended earlyNCT04924413
What this trial is testing

L-TIL Plus Tislelizumab as First-line Treatment in Advanced Malignant Melanoma

Who this might be right for
Malignant Melanoma
Quanli Gao 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439110
What this trial is testing

Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol Q)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 38
Early research (Phase 1)Study completedNCT03017833
What this trial is testing

Sapanisertib and Metformin in Treating Patients With Advanced or Metastatic Relapsed or Refractory Cancers

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm+1 more
M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)Ended earlyNCT02050321
What this trial is testing

A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma

Who this might be right for
Malignant Melanoma
University of Arizona 2
Early research (Phase 1)Study completedNCT00037817
What this trial is testing

Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies

Who this might be right for
Advanced Esophageal CancersPrimary Small Cell Lung CancersNon-Small-Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 34
Early research (Phase 1)Looking for participantsNCT05877924
What this trial is testing

NBL-020 Injection in Subjects With Advanced Malignant Tumors.

Who this might be right for
Advanced Malignant Tumors
NovaRock Biotherapeutics, Ltd 200
Early research (Phase 1)Study completedNCT02159989
What this trial is testing

Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmFibrolamellar CarcinomaMetastatic Malignant Solid Neoplasm+5 more
National Cancer Institute (NCI) 83
Early research (Phase 1)Study completedNCT02526017
What this trial is testing

Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers

Who this might be right for
Advanced Solid TumorsHead and Neck CancerPancreatic Cancer+4 more
Five Prime Therapeutics, Inc. 313
Early research (Phase 1)UnknownNCT05829057
What this trial is testing

The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1

Who this might be right for
Esophagus CancerBladder CancerLiver Cancer+2 more
Zhejiang University 10
Not applicableWithdrawnNCT03115528
What this trial is testing

Difference in the Estimation of Prognosis

Who this might be right for
Malignant Neoplasms of Independent (Primary) Multiple Sites
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Study completedNCT05809336
What this trial is testing

Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Beijing Friendship Hospital 172
Testing effectiveness (Phase 2)WithdrawnNCT00668499
What this trial is testing

VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma

Who this might be right for
Mesothelioma
University of Southern California
Testing effectiveness (Phase 2)Study completedNCT00060944
What this trial is testing

Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer

Who this might be right for
LiposarcomaLeiomyosarcoma
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 271
Next Page